Advertisement
Advertisement
U.S. markets open in 36 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Anika Therapeutics, Inc. (ANIK)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
22.51+0.32 (+1.44%)
At close: 04:00PM EDT
22.51 0.00 (0.00%)
After hours: 04:10PM EDT
Advertisement
Advertisement
Show:
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Total Revenue
150,195
147,794
130,457
114,610
105,555
Cost of Revenue
66,422
64,851
61,431
28,747
31,280
Gross Profit
83,773
82,943
69,026
85,863
74,275
Operating Expense
102,245
101,423
83,494
51,615
52,526
Operating Income
-18,472
-18,480
-14,468
34,248
21,749
Net Non Operating Interest Income Expense
-299
-188
-302
1,873
1,458
Other Income Expense
-
21,095
-13,854
-
-
Pretax Income
-2,496
2,427
-28,624
36,121
23,207
Tax Provision
-859
-1,707
-4,642
8,928
4,485
Net Income Common Stockholders
-1,637
4,134
-23,982
27,193
18,722
Diluted NI Available to Com Stockholders
-1,637
4,134
-23,982
27,193
18,722
Basic EPS
-
0.29
-1.69
1.93
1.30
Diluted EPS
-
0.28
-1.69
1.89
1.27
Basic Average Shares
-
14,401
14,222
14,121
14,442
Diluted Average Shares
-
14,634
14,222
14,374
14,689
Total Operating Income as Reported
-2,197
2,615
-28,322
34,248
21,749
Total Expenses
168,667
166,274
144,925
80,362
83,806
Net Income from Continuing & Discontinued Operation
-1,637
4,134
-23,982
27,193
18,722
Normalized Income
-12,311
-11,265
-12,372
27,193
18,722
Net Interest Income
-299
-188
-302
1,873
1,458
EBIT
-18,472
-18,480
-14,468
34,248
21,749
EBITDA
-4,046
-
-
-
-
Reconciled Cost of Revenue
66,422
64,851
61,431
28,747
31,280
Reconciled Depreciation
14,426
14,317
13,464
5,991
5,910
Net Income from Continuing Operation Net Minority Interest
-1,637
4,134
-23,982
27,193
18,722
Total Unusual Items Excluding Goodwill
16,275
21,095
-13,854
-
-
Total Unusual Items
16,275
21,095
-13,854
-
-
Normalized EBITDA
-20,321
-25,258
12,850
40,239
27,659
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
5,601
5,696
-2,244
0
0
Advertisement
Advertisement